ArTS Archivio della ricerca di Trieste
ArTS è il sistema di gestione integrata dei dati della ricerca adottato dall' Università degli Studi di Trieste
EnglishThe incidence of venous thromboembolism (VTE) after hip and knee major surgery without prophylaxis ranges from 29% to 60% for deep vein thrombosis (DVT) and from 1% to 3% for fatal pulmonary embolism (PE)1-3; consequently, thromboprophylaxis in this clinical setting is strongly recom- mended by experts and international consensus guidelines.3 Conversely, limited information is available on the rate of VTE complications and thromboprophylaxis use in other orthopae- dic surgeries, such as shoulder arthroscopy.4 To the best of our knowledge, the incidence and risk factors for VTE in shoulder arthroscopy haven’t been investigated in prospective epide- miological studies. Some independent, retrospective, obser- vational studies and case series have reported a quite low VTE rate in shoulder arthroscopy5-12; moreover, a few infor- mation is available on the safety and efficacy of thrombopro- phylaxis in this setting. Thus, current guidelines on the prevention of VTE in patients undergoing orthopedic surgery do not have a specific recommendation for those undergoing shoulder arthroscopy.3Here, we report the results of the RECOS registry in the spe- cific group of patients undergoing shoulder arthroscopy.
| Titolo: | Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy: Findings From the RECOS Registry | |
| Autori: | ||
| Data di pubblicazione: | 2015 | |
| Rivista: | ||
| Abstract: | The incidence of venous thromboembolism (VTE) after hip and knee major surgery without prophylaxis ranges from 29% to 60% for deep vein thrombosis (DVT) and from 1% to 3% for fatal pulmonary embolism (PE)1-3; consequently, thromboprophylaxis in this clinical setting is strongly recom- mended by experts and international consensus guidelines.3 Conversely, limited information is available on the rate of VTE complications and thromboprophylaxis use in other orthopae- dic surgeries, such as shoulder arthroscopy.4 To the best of our knowledge, the incidence and risk factors for VTE in shoulder arthroscopy haven’t been investigated in prospective epide- miological studies. Some independent, retrospective, obser- vational studies and case series have reported a quite low VTE rate in shoulder arthroscopy5-12; moreover, a few infor- mation is available on the safety and efficacy of thrombopro- phylaxis in this setting. Thus, current guidelines on the prevention of VTE in patients undergoing orthopedic surgery do not have a specific recommendation for those undergoing shoulder arthroscopy.3Here, we report the results of the RECOS registry in the spe- cific group of patients undergoing shoulder arthroscopy. | |
| Handle: | http://hdl.handle.net/11368/2871765 | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1177/1076029614567311 | |
| URL: | http://cat.sagepub.com/content/21/5/486.full.pdf+html | |
| Appare nelle tipologie: | 1.1 Articolo in Rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy.pdf | Documento in Versione Editoriale | Digital Rights Management non definito | Administrator Richiedi una copia |
